Nuance Pharma Announces Approval of IND Application for Pivotal Clinical Trials of Ensifentrine for COPD in China Oltnews, 19 Aug 2022 SHANGHAI, August 18, 2022 /PRNewswire/ — Nuance Pharma (“the Company”) announces that the Center for Drug Evaluation (“CDE”…